Detailed information for compound 944125

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 451.439 | Formula: C22H24F3N3O4
  • H donors: 3 H acceptors: 2 LogP: 4.39 Rotable bonds: 10
    Rule of 5 violations (Lipinski): 1
  • SMILES: CNC(=O)c1ccc(cc1)O[C@@H]1CC[C@@H](CC1)NC(=O)Nc1ccc(cc1)OC(F)(F)F
  • InChi: 1S/C22H24F3N3O4/c1-26-20(29)14-2-8-17(9-3-14)31-18-10-4-15(5-11-18)27-21(30)28-16-6-12-19(13-7-16)32-22(23,24)25/h2-3,6-9,12-13,15,18H,4-5,10-11H2,1H3,(H,26,29)(H2,27,28,30)/t15-,18+
  • InChiKey: JNPWHXLRBKEIPP-RHNCMZPLSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trypanosoma brucei 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.1945 0.4169 0.4169
Leishmania major 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.4558 1 1
Echinococcus multilocularis raf serine:threonine protein kinase 0.0262 0.0412 0.0412
Mycobacterium leprae conserved hypothetical protein 0.0077 0 0.5
Echinococcus granulosus raf serine:threonine protein kinase 0.0262 0.0412 0.0412
Trypanosoma cruzi 6-phosphofructo-2-kinase 1 0.4481 0.9828 0.9828
Trypanosoma cruzi 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.1945 0.4169 0.4169
Mycobacterium ulcerans epoxide hydrolase EphA 0.1498 0.3172 0.5439
Mycobacterium leprae Possible phosphoglycerate mutase 0.0077 0 0.5
Trypanosoma cruzi 6-phosphofructo-2-kinase 1 0.4481 0.9828 0.9828
Mycobacterium leprae Probable phosphoglycerate mutase (phosphoglyceromutase) (phosphoglycerate phosphomutase) 0.0077 0 0.5
Onchocerca volvulus 0.4558 1 1
Trypanosoma brucei 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.4558 1 1
Mycobacterium leprae PROBABLE PHOSPHOGLYCERATE MUTASE 1 GPM1 (PHOSPHOGLYCEROMUTASE) (PGAM) (BPG-DEPENDENT PGAM) 0.0077 0 0.5
Entamoeba histolytica purine nucleoside phosphorylase, putative 0.018 0.0229 0.0393
Giardia lamblia Hypothetical protein 0.269 0.5831 0.5
Echinococcus multilocularis 6 phosphofructo 2 kinase:fructose 2 0.4558 1 1
Giardia lamblia Hypothetical protein 0.269 0.5831 0.5
Chlamydia trachomatis 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase 0.0077 0 0.5
Mycobacterium leprae conserved hypothetical protein 0.0077 0 0.5
Loa Loa (eye worm) hypothetical protein 0.4558 1 1
Brugia malayi Raf kinase 0.0253 0.0392 1
Trichomonas vaginalis purine nucleoside phosphorylase, putative 0.018 0.0229 1
Mycobacterium ulcerans fructose-2,6-bisphosphatase GpmB 0.269 0.5831 1
Schistosoma mansoni serine/threonine protein kinase 0.0262 0.0412 0.0412
Mycobacterium tuberculosis Probable epoxide hydrolase EphA (epoxide hydratase) (arene-oxide hydratase) 0.1498 0.3172 1
Leishmania major 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase-1-like protein 0.1945 0.4169 0.4169
Trypanosoma cruzi 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.4558 1 1
Treponema pallidum purine nucleoside phosphorylase (deoD) 0.018 0.0229 1
Mycobacterium ulcerans hypothetical protein 0.269 0.5831 1
Entamoeba histolytica purine nucleoside phosphorylase, putative 0.018 0.0229 0.0393
Leishmania major 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.4481 0.9828 0.9828
Mycobacterium leprae probable isochorismate synthase EntC 0.0077 0 0.5
Trichomonas vaginalis purine nucleoside phosphorylase, putative 0.018 0.0229 1
Plasmodium falciparum purine nucleoside phosphorylase 0.018 0.0229 1
Loa Loa (eye worm) raf kinase 0.026 0.0409 0.0409
Mycobacterium leprae PROBABLE PHOSPHOGLYCERATE MUTASE (PHOSPHOGLYCEROMUTASE) 0.0077 0 0.5
Trypanosoma brucei 6-phosphofructo-2-kinase 2 0.4481 0.9828 0.9828
Entamoeba histolytica phosphoglycerate mutase family protein, putative 0.269 0.5831 1
Treponema pallidum uridine phosphorylase (udp) 0.018 0.0229 1
Mycobacterium leprae conserved hypothetical protein 0.0077 0 0.5
Trypanosoma cruzi 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.1945 0.4169 0.4169
Loa Loa (eye worm) TKL/RAF/RAF protein kinase 0.0148 0.0159 0.0159
Mycobacterium leprae POSSIBLE HYDROLASE MUTT1 0.0077 0 0.5
Loa Loa (eye worm) hypothetical protein 0.2613 0.566 0.566
Plasmodium vivax purine nucleoside phosphorylase, putative 0.018 0.0229 1
Loa Loa (eye worm) hypothetical protein 0.4481 0.9828 0.9828
Schistosoma mansoni 6-phosphofructokinase 0.4558 1 1
Toxoplasma gondii Purine nucleoside phosphorylase 0.018 0.0229 1
Trypanosoma cruzi 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.4558 1 1

Activities

Activity type Activity value Assay description Source Reference
Stabilty (ADMET) = 101 % Stability in human liver microsomes assessed as compound remaining at 1 uM after 30 mins by mass spectrometry ChEMBL. 25479771

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.